Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OzoParQTmicrob: Gut Microbiome in CIPN Treated With Ozone
NCT06799351Phase 3Recruiting
- Start
- Feb 2025
- Primary completion
- Dec 2029
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of medical ozonated water in chemotherapy-induced peripheral neuropathy (CIPN). Started Feb 2025; status: recruiting.
02
Drugs
medical ozonated water
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT06799351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06799351.